Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature

Antoni Ribas; Caroline Robert; F. Stephen Hodi; Jedd D. Wolchok; Anthony M. Joshua; Wen-Jen Hwu; Jeffrey S. Weber; Hassane M. Zarour; Richard Kefford; Andrey Loboda; Andrew Albright; Soonmo Peter Kang; Scot Ebbinghaus; Jennifer Yearley; Erin Murphy; Michael Nebozhyn; Jared K. Lunceford; Terri McClanahan; Mark Ayers; Adil Daud

doi:10.1200/jco.2015.33.15_suppl.3001

Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature

Antoni Ribas, Caroline Robert, F. Stephen Hodi, Jedd D. Wolchok, Anthony M. Joshua, Wen-Jen Hwu, Jeffrey S. Weber, Hassane M. Zarour, Richard Kefford, Andrey Loboda, Andrew Albright, Soonmo Peter Kang, Scot Ebbinghaus, Jennifer Yearley, Erin Murphy, Michael Nebozhyn, Jared K. Lunceford, Terri McClanahan, Mark Ayers, Adil Daud

Department of Biomedical Sciences

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	3001
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	33
Issue number	15 supplement
DOIs	https://doi.org/10.1200/jco.2015.33.15_suppl.3001
Publication status	Published - 20 May 2015
Event	Annual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States Duration: 31 May 2013 → 4 Jun 2013

Access to Document

10.1200/jco.2015.33.15_suppl.3001

Cite this

Ribas, A., Robert, C., Hodi, F. S., Wolchok, J. D., Joshua, A. M., Hwu, W-J., Weber, J. S., Zarour, H. M., Kefford, R., Loboda, A., Albright, A., Kang, S. P., Ebbinghaus, S., Yearley, J., Murphy, E., Nebozhyn, M., Lunceford, J. K., McClanahan, T., Ayers, M., & Daud, A. (2015). Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature. Journal of Clinical Oncology, 33(15 supplement), 3001. https://doi.org/10.1200/jco.2015.33.15_suppl.3001

Ribas, Antoni ; Robert, Caroline ; Hodi, F. Stephen ; Wolchok, Jedd D. ; Joshua, Anthony M. ; Hwu, Wen-Jen ; Weber, Jeffrey S. ; Zarour, Hassane M. ; Kefford, Richard ; Loboda, Andrey ; Albright, Andrew ; Kang, Soonmo Peter ; Ebbinghaus, Scot ; Yearley, Jennifer ; Murphy, Erin ; Nebozhyn, Michael ; Lunceford, Jared K. ; McClanahan, Terri ; Ayers, Mark ; Daud, Adil. / Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature. In: Journal of Clinical Oncology. 2015 ; Vol. 33, No. 15 supplement. pp. 3001.

@article{9f8e9b8eab1f4fa19b7acedc19259573,

title = "Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature",

author = "Antoni Ribas and Caroline Robert and Hodi, {F. Stephen} and Wolchok, {Jedd D.} and Joshua, {Anthony M.} and Wen-Jen Hwu and Weber, {Jeffrey S.} and Zarour, {Hassane M.} and Richard Kefford and Andrey Loboda and Andrew Albright and Kang, {Soonmo Peter} and Scot Ebbinghaus and Jennifer Yearley and Erin Murphy and Michael Nebozhyn and Lunceford, {Jared K.} and Terri McClanahan and Mark Ayers and Adil Daud",

year = "2015",

month = may,

day = "20",

doi = "10.1200/jco.2015.33.15_suppl.3001",

language = "English",

volume = "33",

pages = "3001",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "American Society of Clinical Oncology",

number = "15 supplement",

note = "Annual Meeting of the American Society of Clinical Oncology (ASCO) ; Conference date: 31-05-2013 Through 04-06-2013",

}

Ribas, A, Robert, C, Hodi, FS, Wolchok, JD, Joshua, AM, Hwu, W-J, Weber, JS, Zarour, HM, Kefford, R, Loboda, A, Albright, A, Kang, SP, Ebbinghaus, S, Yearley, J, Murphy, E, Nebozhyn, M, Lunceford, JK, McClanahan, T, Ayers, M & Daud, A 2015, 'Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature', Journal of Clinical Oncology, vol. 33, no. 15 supplement, pp. 3001. https://doi.org/10.1200/jco.2015.33.15_suppl.3001

Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature. / Ribas, Antoni; Robert, Caroline; Hodi, F. Stephen; Wolchok, Jedd D.; Joshua, Anthony M.; Hwu, Wen-Jen; Weber, Jeffrey S.; Zarour, Hassane M.; Kefford, Richard; Loboda, Andrey; Albright, Andrew; Kang, Soonmo Peter; Ebbinghaus, Scot; Yearley, Jennifer; Murphy, Erin; Nebozhyn, Michael; Lunceford, Jared K.; McClanahan, Terri; Ayers, Mark; Daud, Adil.

In: Journal of Clinical Oncology, Vol. 33, No. 15 supplement, 20.05.2015, p. 3001.

Research output: Contribution to journal › Meeting abstract

TY - JOUR

T1 - Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature

AU - Ribas, Antoni

AU - Robert, Caroline

AU - Hodi, F. Stephen

AU - Wolchok, Jedd D.

AU - Joshua, Anthony M.

AU - Hwu, Wen-Jen

AU - Weber, Jeffrey S.

AU - Zarour, Hassane M.

AU - Kefford, Richard

AU - Loboda, Andrey

AU - Albright, Andrew

AU - Kang, Soonmo Peter

AU - Ebbinghaus, Scot

AU - Yearley, Jennifer

AU - Murphy, Erin

AU - Nebozhyn, Michael

AU - Lunceford, Jared K.

AU - McClanahan, Terri

AU - Ayers, Mark

AU - Daud, Adil

PY - 2015/5/20

Y1 - 2015/5/20

U2 - 10.1200/jco.2015.33.15_suppl.3001

DO - 10.1200/jco.2015.33.15_suppl.3001

M3 - Meeting abstract

VL - 33

SP - 3001

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 1527-7755

IS - 15 supplement

T2 - Annual Meeting of the American Society of Clinical Oncology (ASCO)

Y2 - 31 May 2013 through 4 June 2013

ER -